Atai Beckley N.V
ATAI
Cena:
$ 4.32
-0.01 (-0.23%)
Valuace
70
Růst
0
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
ATAIBECKLEY PARTICIPATES IN THE 64TH ANNUAL ACNP MEETING WITH TWO SCIENTIFIC POSTER PRESENTATIONS AND HOT TOPIC PRESENTATION
16-01-2026
NEW YORK, JAN. 16, 2026 (GLOBE NEWSWIRE) -- ATAIBECKLEY INC. (NASDAQ: ATAI) (“ATAIBECKLEY” OR ...
Více zde
ATAIBECKLEY PROVIDES UPDATE AND OUTLOOK FOR 2026 AHEAD OF J.P. MORGAN HEALTHCARE CONFERENCE
08-01-2026
NEW YORK, JAN. 08, 2026 (GLOBE NEWSWIRE) -- ATAIBECKLEY INC (NASDAQ: ATAI) (“ATAIBECKLEY” OR THE...
Více zde
ATAIBECKLEY ADDED TO THE NASDAQ BIOTECHNOLOGY INDEX (NBI)
23-12-2025
NEW YORK AND AMSTERDAM, DEC. 23, 2025 (GLOBE NEWSWIRE) -- ATAI BECKLEY N.V. (NASDAQ: ATAI) (“ATAIB...
Více zde
ENHANCED FORTIFIES EXECUTIVE LEADERSHIP TEAM & BOARD OF DIRECTORS
19-11-2025
– CO-FOUNDER MAXIMILIAN MARTIN APPOINTED CEO – – CO-FOUNDER CHRISTIAN ANGERMAYER APPOINTED EXE...
Více zde
ATAI LIFE SCIENCES ANNOUNCES CLOSING OF PUBLIC OFFERING AND FULL EXERCISE OF OPTION TO PURCHASE ADDITIONAL COMMON SHARES
20-10-2025
CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AND OTHER LIQUID ASSETS EXPECTED TO FUND OPERATIONS I...
Více zde
ATAI LIFE SCIENCES ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON SHARES
16-10-2025
NEW YORK AND AMSTERDAM, OCT. 16, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATA...
Více zde
ATAI LIFE SCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
16-10-2025
NEW YORK AND AMSTERDAM, OCT. 16, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI...
Více zde
ATAI LIFE SCIENCES AND BECKLEY PSYTECH ANNOUNCE U.S. FDA BREAKTHROUGH THERAPY DESIGNATION GRANTED TO BPL-003, UNDERSCORING ITS POTENTIAL IN TREATMENT-RESISTANT DEPRESSION
16-10-2025
NEW YORK AND AMSTERDAM, OCT. 16, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI...
Více zde
ATAI LIFE SCIENCES AND BECKLEY PSYTECH REPORT POSITIVE PHASE 2A DATA DEMONSTRATING IMPROVED OUTCOMES WITH A TWO-DOSE INDUCTION REGIMEN OF BPL-003 IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
23-09-2025
NEW YORK AND AMSTERDAM AND OXFORD, UNITED KINGDOM, SEPT. 23, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIE...
Více zde
ATAI LIFE SCIENCES TO PARTICIPATE IN SEPTEMBER INVESTOR CONFERENCES
28-08-2025
NEW YORK AND AMSTERDAM, AUG. 28, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI...
Více zde
RECOGNIFY LIFE SCIENCES PROVIDES UPDATE ON PHASE 2B TRIAL OF INIDASCAMINE IN PATIENTS WITH COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA
25-07-2025
SOUTH SAN FRANCISCO, JULY 25, 2025 (GLOBE NEWSWIRE) -- RECOGNIFY LIFE SCIENCES, A CLINICAL-STAGE BIO...
Více zde
ATAI LIFE SCIENCES ANNOUNCES $50 MILLION PRIVATE PLACEMENT FINANCING
01-07-2025
FINANCING CO-LED BY FERRING VENTURES S.A. AND APEIRON INVESTMENT LTD. WITH PARTICIPATION FROM NEW AN...
Více zde
ATAI LIFE SCIENCES AND BECKLEY PSYTECH ANNOUNCE POSITIVE TOPLINE RESULTS FROM THE PHASE 2B STUDY OF BPL-003 IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
01-07-2025
NEW YORK, AND AMSTERDAM AND OXFORD, UNITED KINGDOM, JULY 01, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SC...
Více zde
HAPPY FATHER'S DAY! AND $HAREHOLDER ALERT: CLASS ACTION ATTORNEY JUAN MONTEVERDE INVESTIGATES THE MERGER OF ATAI LIFE SCIENCES N.V.
15-06-2025
NEW YORK, JUNE 15, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ...
Více zde
ATAI STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF ATAI LIFE SCIENCES N.V. IS FAIR TO SHAREHOLDERS
03-06-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde
ATAI LIFE SCIENCES AND BECKLEY PSYTECH TO COMBINE CREATING A GLOBAL LEADER IN PSYCHEDELIC MENTAL HEALTH THERAPIES
02-06-2025
NEW YORK AND BERLIN AND OXFORD, UNITED KINGDOM, JUNE 02, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES...
Více zde
ATAI LIFE SCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
29-05-2025
NEW YORK AND BERLIN, MAY 29, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI...
Více zde
ATAI LIFE SCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PART 2 OF BECKLEY PSYTECH'S PHASE 2A STUDY OF BPL-003 IN COMBINATION WITH SSRIS FOR TREATMENT-RESISTANT DEPRESSION
20-05-2025
- POSITIVE RESULTS SHOW THAT A SINGLE DOSE OF BPL-003, ADMINISTERED ADJUNCTIVELY TO SSRIS, PRODUCED ...
Více zde
ATAI LIFE SCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES
14-05-2025
WITH CLINICAL MOMENTUM ACROSS ITS PIPELINE, ATAI STRENGTHENS ITS POSITION AS A LEADER IN POTENTIALLY...
Více zde
ATAI LIFE SCIENCES ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 STUDY OF EMP-01 FOR THE TREATMENT OF SOCIAL ANXIETY DISORDER
13-05-2025
- IN A PHASE 1 STUDY, EMP-01 (ORAL R-MDMA) DEMONSTRATED A UNIQUE, DOSE-DEPENDENT SUBJECTIVE EFFECT P...
Více zde
ATAI LIFE SCIENCES ANNOUNCES FIRST PATIENT DOSED IN ELUMINA, THE PHASE 2 CLINICAL TRIAL OF VLS-01 FOR TREATMENT-RESISTANT DEPRESSION
11-03-2025
- ELUMINA IS A PHASE 2, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CLINICAL TRIAL TO...
Více zde
ATAI LIFE SCIENCES TO PARTICIPATE IN THE TD COWEN 45TH ANNUAL HEALTH CARE CONFERENCE
24-02-2025
NEW YORK AND BERLIN, FEB. 24, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI”...
Více zde
ATAI LIFE SCIENCES ANNOUNCES CLOSING OF PUBLIC OFFERING AND FULL EXERCISE OF OPTION TO PURCHASE ADDITIONAL COMMON SHARES
20-02-2025
NEW YORK AND BERLIN, FEB. 20, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI”...
Více zde
ATAI LIFE SCIENCES ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON SHARES
12-02-2025
NEW YORK AND BERLIN, FEB. 12, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI”...
Více zde
ATAI LIFE SCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
12-02-2025
NEW YORK AND BERLIN, FEB. 12, 2025 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI...
Více zde
ATAI LIFE SCIENCES ANNOUNCES KEY LEADERSHIP APPOINTMENTS AS IT ADVANCES ITS PIPELINE OF NOVEL PSYCHEDELIC THERAPEUTICS FOR MENTAL HEALTH
10-01-2025
- SRINIVAS RAO M.D., PH.D. SUCCEEDS AS SOLE CHIEF EXECUTIVE OFFICER - KEVIN CRAIG, M.D. PROMOTED TO ...
Více zde
INTELGENX IS GRANTED COURT APPROVAL OF THE SALE PROPOSAL FROM ATAI LIFE SCIENCES AG
02-10-2024
MONTRÉAL, OCT. 02, 2024 (GLOBE NEWSWIRE) -- INTELGENX TECHNOLOGIES CORP. (THE “COMPANY” OR “I...
Více zde
ATAI LIFE SCIENCES TO PARTICIPATE IN THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE
04-09-2024
NEW YORK AND BERLIN, SEPT. 04, 2024 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI...
Více zde
ATAI LIFE SCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
13-08-2024
• REPORTED POSITIVE PHASE 1B RESULTS OF VLS-01 (BUCCAL FILM DMT); EXPECT TO INITIATE A PHASE 2 STU...
Více zde
ATAI LIFE SCIENCES TO PARTICIPATE IN THE CANACCORD GENUITY 44TH ANNUAL GROWTH CONFERENCE
07-08-2024
NEW YORK AND BERLIN, AUG. 07, 2024 (GLOBE NEWSWIRE) -- ATAI LIFE SCIENCES (NASDAQ: ATAI) (“ATAI...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2025-12-05 00:00:00 | 8-K | Stáhnout | |
| 2025-11-12 00:00:00 | 8-K | Stáhnout | |
| 2025-11-12 00:00:00 | 10-Q | Stáhnout | |
| 2025-11-05 00:00:00 | 8-K | Stáhnout | |
| 2025-11-04 00:00:00 | 8-K | Stáhnout | |
| 2025-10-27 00:00:00 | 8-K | Stáhnout | |
| 2025-10-21 01:00:00 | 8-K | Stáhnout | |
| 2025-10-21 00:00:00 | 8-K | Stáhnout | |
| 2025-10-16 01:00:00 | 8-K | Stáhnout | |
| 2025-10-16 00:00:00 | 8-K | Stáhnout | |
| 2025-10-10 01:00:00 | 8-K | Stáhnout | |
| 2025-10-10 00:00:00 | 8-K | Stáhnout | |
| 2025-09-29 01:00:00 | 8-K | Stáhnout | |
| 2025-09-29 00:00:00 | 8-K | Stáhnout | |
| 2025-09-23 01:00:00 | 8-K | Stáhnout | |
| 2025-09-23 00:00:00 | 8-K | Stáhnout | |
| 2025-08-14 01:00:00 | 8-K | Stáhnout | |
| 2025-08-14 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-14 00:00:00 | 8-K | Stáhnout | |
| 2025-08-14 00:00:00 | 10-Q | Stáhnout | |
| 2025-07-01 01:00:00 | 8-K | Stáhnout | |
| 2025-07-01 00:00:00 | 8-K | Stáhnout | |
| 2025-06-02 01:00:00 | 8-K | Stáhnout | |
| 2025-06-02 00:00:00 | 8-K | Stáhnout | |
| 2025-05-21 01:00:00 | 8-K | Stáhnout | |
| 2025-05-21 00:00:00 | 8-K | Stáhnout | |
| 2025-05-14 01:00:00 | 8-K | Stáhnout | |
| 2025-05-14 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-14 00:00:00 | 8-K | Stáhnout | |
| 2025-05-14 00:00:00 | 10-Q | Stáhnout | |
| 2025-05-08 01:00:00 | 8-K | Stáhnout | |
| 2025-05-08 00:00:00 | 8-K | Stáhnout | |
| 2025-04-30 01:00:00 | 8-K | Stáhnout | |
| 2025-04-30 00:00:00 | 8-K | Stáhnout | |
| 2025-03-20 00:00:00 | 8-K | Stáhnout | |
| 2025-03-19 23:00:00 | 8-K | Stáhnout | |
| 2025-03-17 00:00:00 | 8-K | Stáhnout | |
| 2025-03-17 00:00:00 | 10-K | Stáhnout | |
| 2025-03-16 23:00:00 | 8-K | Stáhnout | |
| 2025-03-16 23:00:00 | 10-K | Stáhnout | |
| 2025-02-13 00:00:00 | 8-K | Stáhnout | |
| 2025-02-12 23:00:00 | 8-K | Stáhnout | |
| 2025-01-24 00:00:00 | 8-K | Stáhnout | |
| 2025-01-23 23:00:00 | 8-K | Stáhnout | |
| 2025-01-10 00:00:00 | 8-K | Stáhnout | |
| 2025-01-09 23:00:00 | 8-K | Stáhnout | |
| 2024-11-13 00:00:00 | 8-K | Stáhnout | |
| 2024-11-13 00:00:00 | 10-Q | Stáhnout | |
| 2024-11-12 23:00:00 | 8-K | Stáhnout | |
| 2024-11-12 23:00:00 | 10-Q | Stáhnout | |
| 2024-10-04 01:00:00 | 8-K | Stáhnout | |
| 2024-10-04 00:00:00 | 8-K | Stáhnout | |
| 2024-08-14 01:00:00 | 8-K | Stáhnout | |
| 2024-08-14 00:00:00 | 8-K | Stáhnout | |
| 2024-08-13 01:00:00 | 8-K | Stáhnout | |
| 2024-08-13 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-13 00:00:00 | 8-K | Stáhnout | |
| 2024-08-13 00:00:00 | 10-Q | Stáhnout | |
| 2024-06-05 01:00:00 | 8-K | Stáhnout | |
| 2024-06-05 00:00:00 | 8-K | Stáhnout | |
| 2024-05-23 01:00:00 | 8-K | Stáhnout | |
| 2024-05-23 00:00:00 | 8-K | Stáhnout | |
| 2024-05-15 01:00:00 | 8-K | Stáhnout | |
| 2024-05-15 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-15 00:00:00 | 8-K | Stáhnout | |
| 2024-05-15 00:00:00 | 10-Q | Stáhnout | |
| 2024-03-28 00:00:00 | 8-K | Stáhnout | |
| 2024-03-28 00:00:00 | 10-K | Stáhnout | |
| 2024-03-27 23:00:00 | 8-K | Stáhnout | |
| 2024-03-27 23:00:00 | 10-K | Stáhnout | |
| 2024-02-06 00:00:00 | 8-K | Stáhnout | |
| 2024-02-05 23:00:00 | 8-K | Stáhnout | |
| 2024-01-23 00:00:00 | 8-K | Stáhnout | |
| 2024-01-22 23:00:00 | 8-K | Stáhnout | |
| 2024-01-09 00:00:00 | 8-K | Stáhnout | |
| 2024-01-08 23:00:00 | 8-K | Stáhnout | |
| 2024-01-04 00:00:00 | 8-K | Stáhnout | |
| 2024-01-03 23:00:00 | 8-K | Stáhnout | |
| 2023-11-14 00:00:00 | 10-Q | Stáhnout | |
| 2023-11-13 23:00:00 | 10-Q | Stáhnout | |
| 2023-10-13 01:00:00 | 8-K | Stáhnout | |
| 2023-10-13 00:00:00 | 8-K | Stáhnout | |
| 2023-09-29 01:00:00 | 8-K | Stáhnout | |
| 2023-09-29 00:00:00 | 8-K | Stáhnout | |
| 2023-08-31 01:00:00 | 8-K | Stáhnout | |
| 2023-08-31 00:00:00 | 8-K | Stáhnout | |
| 2023-08-10 01:00:00 | 8-K | Stáhnout | |
| 2023-08-10 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-10 00:00:00 | 8-K | Stáhnout | |
| 2023-08-10 00:00:00 | 10-Q | Stáhnout | |
| 2023-05-31 01:00:00 | 8-K | Stáhnout | |
| 2023-05-31 00:00:00 | 8-K | Stáhnout | |
| 2023-05-17 01:00:00 | 8-K | Stáhnout | |
| 2023-05-17 00:00:00 | 8-K | Stáhnout | |
| 2023-05-11 01:00:00 | 8-K | Stáhnout | |
| 2023-05-11 01:00:00 | 10-Q | Stáhnout | |
| 2023-05-11 00:00:00 | 8-K | Stáhnout | |
| 2023-05-11 00:00:00 | 10-Q | Stáhnout | |
| 2023-03-24 00:00:00 | 8-K | Stáhnout | |
| 2023-03-24 00:00:00 | 10-K | Stáhnout | |
| 2023-03-23 23:00:00 | 8-K | Stáhnout | |
| 2023-03-23 23:00:00 | 10-K | Stáhnout | |
| 2022-11-10 00:00:00 | 8-K | Stáhnout | |
| 2022-11-10 00:00:00 | 10-Q | Stáhnout | |
| 2022-11-09 23:00:00 | 8-K | Stáhnout | |
| 2022-11-09 23:00:00 | 10-Q | Stáhnout | |
| 2022-11-08 00:00:00 | 8-K | Stáhnout | |
| 2022-11-07 23:00:00 | 8-K | Stáhnout | |
| 2022-10-14 01:00:00 | 8-K | Stáhnout | |
| 2022-10-14 00:00:00 | 8-K | Stáhnout | |
| 2022-08-15 01:00:00 | 8-K | Stáhnout | |
| 2022-08-15 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-15 00:00:00 | 8-K | Stáhnout | |
| 2022-08-15 00:00:00 | 10-Q | Stáhnout | |
| 2022-08-01 01:00:00 | 8-K | Stáhnout | |
| 2022-08-01 00:00:00 | 8-K | Stáhnout | |
| 2022-06-17 01:00:00 | 8-K | Stáhnout | |
| 2022-06-17 00:00:00 | 8-K | Stáhnout | |
| 2022-05-27 01:00:00 | 8-K | Stáhnout | |
| 2022-05-27 00:00:00 | 8-K | Stáhnout | |
| 2022-05-16 01:00:00 | 8-K | Stáhnout | |
| 2022-05-16 01:00:00 | 10-Q | Stáhnout | |
| 2022-05-16 00:00:00 | 8-K | Stáhnout | |
| 2022-05-16 00:00:00 | 10-Q | Stáhnout | |
| 2022-03-30 01:00:00 | 8-K | Stáhnout | |
| 2022-03-30 01:00:00 | 10-K | Stáhnout | |
| 2022-03-30 00:00:00 | 8-K | Stáhnout | |
| 2022-03-30 00:00:00 | 10-K | Stáhnout | |
| 2021-12-15 00:00:00 | 8-K | Stáhnout | |
| 2021-12-14 23:00:00 | 8-K | Stáhnout | |
| 2021-11-15 00:00:00 | 8-K | Stáhnout | |
| 2021-11-15 00:00:00 | 10-Q | Stáhnout | |
| 2021-11-14 23:00:00 | 8-K | Stáhnout | |
| 2021-11-14 23:00:00 | 10-Q | Stáhnout | |
| 2021-08-16 01:00:00 | 8-K | Stáhnout | |
| 2021-08-16 01:00:00 | 10-Q | Stáhnout | |
| 2021-08-16 00:00:00 | 8-K | Stáhnout | |
| 2021-08-16 00:00:00 | 10-Q | Stáhnout | |
| 2021-08-11 01:00:00 | 8-K | Stáhnout | |
| 2021-08-11 00:00:00 | 8-K | Stáhnout | |
| 2021-07-13 01:00:00 | 8-K | Stáhnout | |
| 2021-07-13 00:00:00 | 8-K | Stáhnout |
